A Study on Patent Non-Obvious Subject Matter of Europe and the US from the CRISPR Patent Dispute
碩士 === 國立政治大學 === 科技管理與智慧財產研究所 === 106 === CRISPR-Cas system is an acquired immune system of prokaryotic cells to defense foreign genetic elements. In a study published in 2012 by Emmanuelle Charpentier, a scientist at Umeå University, and Jennifer A. Doudna, a scientist at the University of Califor...
Main Authors: | Huang, Yu-Lun, 黃于倫 |
---|---|
Other Authors: | Chan, Keith |
Format: | Others |
Language: | zh-TW |
Published: |
2017
|
Online Access: | http://ndltd.ncl.edu.tw/handle/ceepee |
Similar Items
-
A Case Study of Patent Appeal,Non-obviousness of Patent Elements As the Center
by: HUANG, MAO-CHANG, et al.
Published: (2017) -
Is it Obvious? A Review and Critique of the Non-obviousness Patent Requirement
by: Hashim, Mohamed
Published: (2012) -
Is it Obvious? A Review and Critique of the Non-obviousness Patent Requirement
by: Hashim, Mohamed
Published: (2012) -
A Study on Non-obviousness of Chemical Invention in US Patent Law
by: Yue-teng Cheng, et al.
Published: (2012) -
Formulation Patents and Dermatology and Obviousness
by: Josephine Liu, et al.
Published: (2011-11-01)